JP4748627B2 - 賦形剤 - Google Patents

賦形剤 Download PDF

Info

Publication number
JP4748627B2
JP4748627B2 JP2000559869A JP2000559869A JP4748627B2 JP 4748627 B2 JP4748627 B2 JP 4748627B2 JP 2000559869 A JP2000559869 A JP 2000559869A JP 2000559869 A JP2000559869 A JP 2000559869A JP 4748627 B2 JP4748627 B2 JP 4748627B2
Authority
JP
Japan
Prior art keywords
trehalose
excipient
particle size
glucose
average particle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2000559869A
Other languages
English (en)
Japanese (ja)
Inventor
和博 大生
悦雄 鎌田
俊一 五味
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Kasei Chemicals Corp
Original Assignee
Asahi Kasei Chemicals Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Kasei Chemicals Corp filed Critical Asahi Kasei Chemicals Corp
Priority to JP2000559869A priority Critical patent/JP4748627B2/ja
Application granted granted Critical
Publication of JP4748627B2 publication Critical patent/JP4748627B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Control And Other Processes For Unpacking Of Materials (AREA)
  • Glass Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Detergent Compositions (AREA)
JP2000559869A 1998-07-15 1999-07-13 賦形剤 Expired - Lifetime JP4748627B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2000559869A JP4748627B2 (ja) 1998-07-15 1999-07-13 賦形剤

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP1998200295 1998-07-15
JP20029598 1998-07-15
JP32356098 1998-11-13
JP1998323560 1998-11-13
PCT/JP1999/003775 WO2000003735A1 (fr) 1998-07-15 1999-07-13 Excipient
JP2000559869A JP4748627B2 (ja) 1998-07-15 1999-07-13 賦形剤

Publications (1)

Publication Number Publication Date
JP4748627B2 true JP4748627B2 (ja) 2011-08-17

Family

ID=26512084

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000559869A Expired - Lifetime JP4748627B2 (ja) 1998-07-15 1999-07-13 賦形剤

Country Status (10)

Country Link
US (1) US6699845B2 (zh)
EP (1) EP1097722B1 (zh)
JP (1) JP4748627B2 (zh)
KR (1) KR100421264B1 (zh)
CN (1) CN1185013C (zh)
AT (1) ATE308343T1 (zh)
AU (1) AU743109B2 (zh)
CA (1) CA2337015C (zh)
DE (1) DE69928110T2 (zh)
WO (1) WO2000003735A1 (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190112179A (ko) * 2017-10-03 2019-10-02 미쯔칸 홀딩즈 씨오., 엘티디. 식품 미립자 복합체 함유 조성물 및 그 제조법

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US20040131672A1 (en) * 2003-01-07 2004-07-08 Nilobon Podhipleux Direct compression pharmaceutical composition containing a pharmaceutically active ingredient with poor flowing properties
EP1460080A1 (en) * 2003-03-21 2004-09-22 Cargill Incorporated Direct compressible trehalose solids
CN1764388B (zh) * 2003-03-26 2010-05-05 株式会社林原生物化学研究所 非糖质成分的粉末化方法及粉末化基剂
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
JP2007131587A (ja) * 2005-11-11 2007-05-31 Activas Pharma:Kk キノリノン誘導体を有効成分とする医薬組成物、及びその製造方法
UA92052C2 (ru) * 2005-12-07 2010-09-27 Нікомед Фарма Ас Предварительно уплотненные кальциесодержащие композиции
CN100391541C (zh) * 2006-03-16 2008-06-04 南台科技大学 以胶质类食材制造赋形剂的方法
EP2001450B1 (en) * 2006-03-31 2019-01-30 Rubicon Research Private Limited Directly compressible composite for orally disintegrating tablets
CN107235980A (zh) 2006-05-04 2017-10-10 勃林格殷格翰国际有限公司 多晶型
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
US20100237530A1 (en) * 2006-06-27 2010-09-23 Daiichi Sankyo Company, Limited Compressed preparation
WO2008079342A2 (en) * 2006-12-21 2008-07-03 Mallinckrodt Inc. Composition of and method for preparing orally disintegrating tablets
AR071175A1 (es) 2008-04-03 2010-06-02 Boehringer Ingelheim Int Composicion farmaceutica que comprende un inhibidor de la dipeptidil-peptidasa-4 (dpp4) y un farmaco acompanante
KR20190016601A (ko) 2008-08-06 2019-02-18 베링거 인겔하임 인터내셔날 게엠베하 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
JP5344938B2 (ja) * 2009-01-29 2013-11-20 旭化成ケミカルズ株式会社 崩壊性固形製剤
ES2760917T3 (es) 2009-11-27 2020-05-18 Boehringer Ingelheim Int Tratamiento de pacientes diabéticos genotipificados con inhibidores DPP-IV como la linagliptina
BR112012028136A2 (pt) 2010-05-05 2016-08-09 Boehringer Ingelheim Int terapia de combinaçao
US9034883B2 (en) 2010-11-15 2015-05-19 Boehringer Ingelheim International Gmbh Vasoprotective and cardioprotective antidiabetic therapy
KR101776032B1 (ko) * 2011-09-21 2017-09-07 가부시기가이샤하야시바라 α,α-트레할로스 이수화물 결정 함유 분말의 제조방법
US9522964B2 (en) * 2012-04-03 2016-12-20 Development, Inc. Micronized starch and methods for manufacturing same
WO2013171167A1 (en) 2012-05-14 2013-11-21 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in the treatment of podocytes related disorders and/or nephrotic syndrome

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH069382A (ja) * 1992-04-17 1994-01-18 Takeda Chem Ind Ltd 安定化された固型製剤およびその製造方法
JPH06217716A (ja) * 1993-01-29 1994-08-09 Morishita Roussel Kk 製剤用添加剤
JPH08104650A (ja) * 1994-03-01 1996-04-23 Asahi Chem Ind Co Ltd 医薬品組成物
JPH09154493A (ja) * 1995-12-11 1997-06-17 Hayashibara Biochem Lab Inc 糖衣固形物及びその製造方法
WO1998005305A1 (en) * 1996-08-06 1998-02-12 Quadrant Holdings Cambridge Ltd. Tablet dosage form of clavulanic acid and amoxycillin comprising a trehalose excipient

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4678812A (en) 1986-05-30 1987-07-07 E. I. Du Pont De Nemours And Company Trehalose as stabilizer and tableting excipient
US4762857A (en) 1986-05-30 1988-08-09 E. I. Du Pont De Nemours And Company Trehalose as stabilizer and tableting excipient
JP3069458B2 (ja) 1992-01-29 2000-07-24 武田薬品工業株式会社 口腔内崩壊型錠剤およびその製造法
WO1993015724A1 (en) 1992-02-18 1993-08-19 Nippon Shinyaku Co., Ltd. Fast soluble tablet
ATE234852T1 (de) 1992-12-28 2003-04-15 Hayashibara Biochem Lab Reinigung von trehalose
JP3559585B2 (ja) * 1993-06-03 2004-09-02 株式会社林原生物化学研究所 トレハロース遊離酵素とその製造方法並びに用途
KR100386391B1 (ko) 1994-01-31 2003-08-30 야마노우치세이야쿠 가부시키가이샤 구강내용해형정제및이의제조방법
TW426737B (en) * 1994-06-27 2001-03-21 Hayashibara Biochem Lab Saccharide composition with reduced reducibility, and preparation and uses thereof
JP3616166B2 (ja) 1994-07-19 2005-02-02 株式会社林原生物化学研究所 トレハロースとその製造方法並びに用途
JP2919771B2 (ja) 1995-04-17 1999-07-19 佐藤製薬株式会社 速溶解性錠剤の製造方法及び該製造方法により製造した速溶解性錠剤
JP3418274B2 (ja) 1995-06-05 2003-06-16 日本化薬株式会社 口腔内感触の良好な錠剤
JPH0948726A (ja) 1995-08-07 1997-02-18 Tanabe Seiyaku Co Ltd 口腔内速崩壊性製剤およびその製法
CA2204599A1 (en) 1995-09-07 1997-03-13 Otsuka Pharmaceutical Co., Ltd. Low-pressure tableted effervescent preparation
BR9714509A (pt) * 1996-02-09 2000-03-21 Quadrant Holdings Cambridge Formulações sólidas contendo trealose
JPH09316006A (ja) 1996-05-29 1997-12-09 Yatsuken:Kk 口腔内溶解性固形製剤
CN1154479C (zh) 1996-06-14 2004-06-23 协和发酵工业株式会社 口腔内快速崩解片剂
TW527195B (en) * 1997-10-09 2003-04-11 Ssp Co Ltd Fast-soluble solid pharmaceutical combinations
JPH11116464A (ja) 1997-10-09 1999-04-27 Ss Pharmaceut Co Ltd 迅速溶解性固形製剤およびその製造法

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH069382A (ja) * 1992-04-17 1994-01-18 Takeda Chem Ind Ltd 安定化された固型製剤およびその製造方法
JPH06217716A (ja) * 1993-01-29 1994-08-09 Morishita Roussel Kk 製剤用添加剤
JPH08104650A (ja) * 1994-03-01 1996-04-23 Asahi Chem Ind Co Ltd 医薬品組成物
JPH09154493A (ja) * 1995-12-11 1997-06-17 Hayashibara Biochem Lab Inc 糖衣固形物及びその製造方法
WO1998005305A1 (en) * 1996-08-06 1998-02-12 Quadrant Holdings Cambridge Ltd. Tablet dosage form of clavulanic acid and amoxycillin comprising a trehalose excipient

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190112179A (ko) * 2017-10-03 2019-10-02 미쯔칸 홀딩즈 씨오., 엘티디. 식품 미립자 복합체 함유 조성물 및 그 제조법
KR102149628B1 (ko) * 2017-10-03 2020-08-28 미쯔칸 홀딩즈 씨오., 엘티디. 식품 미립자 복합체 함유 조성물 및 그 제조법
US11589604B2 (en) 2017-10-03 2023-02-28 Mizkan Holdings Co., Ltd. Composition containing fine food particulate complexes, and method for producing same

Also Published As

Publication number Publication date
CN1309570A (zh) 2001-08-22
CA2337015C (en) 2004-09-07
US20020042393A1 (en) 2002-04-11
US6699845B2 (en) 2004-03-02
EP1097722A1 (en) 2001-05-09
CA2337015A1 (en) 2000-01-27
CN1185013C (zh) 2005-01-19
AU743109B2 (en) 2002-01-17
DE69928110D1 (de) 2005-12-08
KR100421264B1 (ko) 2004-03-18
DE69928110T2 (de) 2006-07-27
EP1097722B1 (en) 2005-11-02
EP1097722A4 (en) 2002-03-20
ATE308343T1 (de) 2005-11-15
KR20010071883A (ko) 2001-07-31
WO2000003735A1 (fr) 2000-01-27
AU4651699A (en) 2000-02-07

Similar Documents

Publication Publication Date Title
JP4748627B2 (ja) 賦形剤
KR101590115B1 (ko) 약학 조성물
JP4213867B2 (ja) 経口用カルシウム組成物の調製方法
JP5650532B2 (ja) 新規マンニトール打錠用賦形剤
KR101435229B1 (ko) 구강내 붕괴정 및 그 제조법
WO2009084678A1 (ja) 口腔内崩壊錠およびその製造方法
US10105314B2 (en) Orodispersible mannitol
WO2003041700A1 (en) Storage stable thyroxine active drug formulations
JP5342028B2 (ja) 口腔内崩壊錠
JP2770934B2 (ja) フルクトースベースの顆粒状生成物及びその製造方法
TWI503122B (zh) Oral administration of pharmaceutical compositions
EP2007384B1 (en) Orodispersible domperidone tablets
JPH08104650A (ja) 医薬品組成物
CA2737380C (en) Tabletting excipient based on lactose and cellulose
JP2004315483A (ja) 口腔内崩壊錠剤
US20110014286A1 (en) Mixture for producing rapidly disintegrating tablets
ES2359377T3 (es) Celulosa microcristalina coprocesada y alcohol de azúcar como excipiente para formulaciones de comprimidos.
WO2011087705A2 (en) Fine particle croscarmellose and uses thereof
JP4596586B2 (ja) トレハロース粒子
JP2007332074A (ja) 口腔内速崩壊錠およびその製造方法
JP4883660B2 (ja) 固形製剤用添加物
WO1999020277A1 (fr) Composition medicamenteuse a dissolution rapide
JP2000072691A (ja) 製剤用添加剤

Legal Events

Date Code Title Description
RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20040303

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060711

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060711

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091222

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100218

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110221

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110411

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20110511

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20110512

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

Ref document number: 4748627

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140527

Year of fee payment: 3

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313111

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

EXPY Cancellation because of completion of term